Double-digit growth seen on corporate scoreboard in Q2, but bank, IT, pharma lag
Economic Times 1 hr ago·26 Oct 2026, 12:56 am
Corporate earnings for the recent quarter showed a strong recovery, with overall revenue and net profit growing by double digits. This positive trend was driven by robust performance across many sectors, signaling a healthy rebound in business activity. However, the banking, IT, and pharmaceuticals sectors lagged behind, experiencing a slowdown in their growth rates compared to the broader market.
For investors, this mixed picture suggests that while the overall economy is gaining momentum, there are pockets of caution. The fact that operating margins improved in non-banking sectors indicates that companies outside the financial and IT industries are performing well. This divergence highlights the importance of looking beyond the headline numbers to understand sector-specific trends.
Moving forward, investors should keep an eye on the upcoming earnings reports from the lagging sectors. Analysts predict that 13 out of 18 sectors will deliver double-digit sales growth in the coming quarters. This forecast offers a positive outlook, but it is essential to monitor how these sectors adapt to the current economic environment to make informed investment decisions.
Excerpt from Economic Times
September quarter earnings exhibited significant revenue and profit growth for various companies in key sectors. Revenue rose by 22.1% with net profit increasing by 27.5%, surpassing the previous quarter. However, banking, IT, and pharmaceuticals sectors experienced a slow down in growth rates. Excluding lending,…Read the original at Economic Times
Key takeaways
- Category: Results.
- AI reads the tone as negative (potentially bearish) for the stock.
- Flagged as a high-impact, market-moving story.
Why it matters
This is a high-impact development and could move the stock. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.
